Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Continuous home monitoring of Parkinson’s disease using inertial sensors: A systematic review

  • Marco Sica ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland

  • Salvatore Tedesco,

    Roles Funding acquisition, Investigation, Writing – review & editing

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland

  • Colum Crowe,

    Roles Investigation, Writing – review & editing

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland

  • Lorna Kenny,

    Roles Writing – review & editing

    Affiliation Centre for Gerontology and Rehabilitation, University College Cork, Cork, Ireland

  • Kevin Moore,

    Roles Writing – review & editing

    Affiliation Centre for Gerontology and Rehabilitation, University College Cork, Cork, Ireland

  • Suzanne Timmons,

    Roles Funding acquisition, Writing – review & editing

    Affiliation Centre for Gerontology and Rehabilitation, University College Cork, Cork, Ireland

  • John Barton,

    Roles Funding acquisition, Writing – review & editing

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland

  • Brendan O’Flynn,

    Roles Funding acquisition, Writing – review & editing

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland

  • Dimitrios-Sokratis Komaris

    Roles Supervision, Writing – review & editing

    Affiliation Tyndall National Institute, University College Cork, Cork, Ireland


Parkinson’s disease (PD) is a progressive neurological disorder of the central nervous system that deteriorates motor functions, while it is also accompanied by a large diversity of non-motor symptoms such as cognitive impairment and mood changes, hallucinations, and sleep disturbance. Parkinsonism is evaluated during clinical examinations and appropriate medical treatments are directed towards alleviating symptoms. Tri-axial accelerometers, gyroscopes, and magnetometers could be adopted to support clinicians in the decision-making process by objectively quantifying the patient’s condition. In this context, at-home data collections aim to capture motor function during daily living and unobstructedly assess the patients’ status and the disease’s symptoms for prolonged time periods. This review aims to collate existing literature on PD monitoring using inertial sensors while it focuses on papers with at least one free-living data capture unsupervised either directly or via videotapes. Twenty-four papers were selected at the end of the process: fourteen investigated gait impairments, eight of which focused on walking, three on turning, two on falls, and one on physical activity; ten articles on the other hand examined symptoms, including bradykinesia, tremor, dyskinesia, and motor state fluctuations in the on/off phenomenon. In summary, inertial sensors are capable of gathering data over a long period of time and have the potential to facilitate the monitoring of people with Parkinson’s, providing relevant information about their motor status. Concerning gait impairments, kinematic parameters (such as duration of gait cycle, step length, and velocity) were typically used to discern PD from healthy subjects, whereas for symptoms’ assessment, researchers were capable of achieving accuracies of over 90% in a free-living environment. Further investigations should be focused on the development of ad-hoc hardware and software capable of providing real-time feedback to clinicians and patients. In addition, features such as the wearability of the system and user comfort, set-up process, and instructions for use, need to be strongly considered in the development of wearable sensors for PD monitoring.


Parkinson’s disease (PD) is a chronic neurological disorder of the central nervous system. Its incidence rises dramatically with age, affecting approximately 6.2 million people worldwide in 2015 [1]. The symptoms of PD are multiple, with the most identifiable being related to motor degeneration. In general, they appear gradually and become more evident with the worsening of the disease, varying from person to person. The diagnosis of PD can be challenging, especially at an early stage, due to the lack of specific tests [2]. The most recognizable symptoms include tremor, rigidity, bradykinesia, and postural instability [3].

Tremor typically appears at the distal part of the limbs, affecting a single arm or leg; it is more pronounced in the upper extremities and it progresses bilaterally with the degeneration of the disease. Rigidity refers to an immoderate, continuous contraction of muscles, and an increased resistance to joint movements. Bradykinesia, as a general term, can be differentiated into akinesia, bradykinesia and hypokinesia, indicating absence, slow or decreased bodily movements, respectively. Akinesia may also include the freezing-of-gait (FoG) phenomenon, which causes sudden and temporary episodes of inability to move forward despite the intention to walk. Postural instability is related to loss of balance and the inability to maintain the upright position, often causing falls or a fear of falling [3].

Despite PD being an irreversible neurodegenerative disorder, medications, such as Levodopa can provide symptomatic relief, particularly in earlier stages [4]. The “on” and “off” phenomenon in Levodopa-treated patients, describes motor fluctuations that occur as the levels of dopamine in the brain drop, followed by a worsening of the motor function: during the "on" state the symptoms are well managed, while in the "off" state they deteriorate. In newly diagnosed people with Parkinson’s (PwP), the response to a single drug intake may last for several hours, whereas with the progression of the disease the drug’s effect is shortened (4 hours or less), and patients need to decrease intervals between doses and/or increase the dosages [5, 6]. Drug-induced dyskinesia (i.e. involuntary abnormal muscle movements [7]) can appear during the “on” state in some patients who have been taking Levodopa for a prolonged period of time.

To ensure the appropriate medical treatment and correct dose of medication for an individual, PwP are infrequently evaluated with qualitative clinical assessments that are based on the subjective judgment of specialists, such as the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), or specifically for dyskinesia, the modified Abnormal Involuntary Movement Scale (m-AIMS) [8, 9]. Yet, due to the heterogeneity and complexity of PD symptoms, such clinical assessments can be challenging and time consuming. Clinicians with different backgrounds and experiences might also vary in their interpretations of the MDS-UPDRS and m-AIMS [10]. Equally, a person’s motor state at a clinic appointment may not be typical of their usual state, enhanced by fatigue, dehydration from travelling or anxiety [10]. Therefore, a clinical assessment is only a snapshot in time, giving little indication of function in a more on or off state. Ultimately, the only way to properly characterize a patient’s motor status is to continuously evaluate their motor function over an extended period of time.

Due to their small-size, light weight, and low-power, wearable motion sensors have already demonstrated their clinical relevance in healthcare [1113] and daily-life monitoring [14, 15]. The most widely used sensors are tri-axial accelerometers, gyroscopes, and magnetometers, commonly combined in an inertial measurement unit (IMU) that can capture three-dimensional orientation, and linear and angular velocities [16, 17]. Thanks to the development of miniaturized hardware technologies capable of collecting and storing large amount of raw data [18], IMUs may offer the opportunity to improve the evaluation of the PD motor symptoms by collecting free-living movements for prolonged period of time outside the laboratory environment. Former studies, such as the one by Bloem et al. [19], have reported that PwP walk better when observed rather than when unsupervised in their daily lives. This is a consequence of the well-known “Hawthorne observation effect” [20]: free-living activities involve a combination of tasks with varying complexities, challenges and distractions that may reduce attention. In addition, numerous episodes related with PD are challenging to detect during laboratory-based observation because of their complexity (i.e. the on/off phenomenon) or rarity (i.e. freezing of gait phenomenon) [21]. As a consequence, a thorough evaluation of a PwP requires the data to be gathered during long observation windows while patients go ahead with normal every day activities.

Previous reviews have already investigated monitoring of PD using body-fixed-sensors [2228]; yet, to our best knowledge, this is the first systematic review to target solely publications on continuous monitoring of PwP with at least one data capture at home. We focused on studies that used only wearable inertial sensor over a long period of time (i.e. from one to fourteen days) and where the data collection was not supervised (either directly or via videotape) by clinicians or caregivers.


This systematic review was performed according to the guidelines of the PRISMA statement [29]. The literature search was conducted in April 2020 on the IEEE Xplore, PubMed, SpringerLink, ACM Digital Library and Web of Science electronic databases with the following search string:

(Parkins*) AND (bradykinesia OR tremor OR rigidity OR hypokinesia OR dyskinesia OR freez* OR akinesia OR fluctuat* OR movement disorder) AND (IMU or inertia* OR acceler* OR gyro* OR wearable OR body-worn) AND (free-living OR daily-living OR continuous OR 24-hour OR home OR unsupervised)

Only original, full-text, peer-reviewed, journal or conference articles in English that were published between January 2010 and April 2020 were included in this review. Case studies, reviews, books, book chapters, editorials, and letters were excluded. Duplicate findings were manually identified and removed.

Three reviewers (MS, ST, and CC) independently screened the title, abstract and key words of the records identified through the database searching. Studies were selected if they monitored or estimated the severity of PD symptoms at home with inertial sensors and their data collection was not supervised by research staff or video cameras. Studies were excluded if the main recording devices were not IMUs, or PD was not the prevalent disorder of the sample population. Subsequently, full text assessment was performed by each reviewer and cases of conflict were debated among them.

The relevant data was extracted from chosen studies and tabularized under predefined headings. Authorship, symptoms monitored, activities, devices (type, number, placement) and data collection (number of assessment days, sample size, use of diaries) were all recorded. Additionally, the studies’ aims, outcome measures, analyses used and results were summarized.

To analyze the risk of bias of the reviewed studies, an adapted version of the AXIS appraisal tool for cross-sectional studies was used, containing thirteen questions that could be answered with a “yes” or “no” [30] (Table 1). A single reviewer scored each study from zero to 13 against the appraisal tool by summing all the positive answers. Papers were categorized as having low (score equal or higher than 11), medium (score between eight and 10) and high (score equal or lower than seven) risk of bias.


Studies selection

The electronic database searches identified 446 records (Fig 1). Ninety-eight duplicates were removed and the remaining 348 articles were screened (229 records excluded). Following full text assessment (95 records excluded) a total of 24 studies were included in the review [3154].

Risk of bias assessment

The appraisal tool yielded six studies with medium and 18 with low risk of bias. Authors reported clear aims and objectives (Q1, 95.8%), study designs (Q2, 95.8%) and selection processes (Q4, 83.3%), however, the sample size was inadequate in 37.5% of the cases (Q3). The outcome variables were appropriate to the aims (Q5, 100%) and measured with the correct instruments (Q6, 100%), while statistics and general methods were reported adequately (Q7, 87.5%; Q8, 79.1%). Results were presented in depth (Q9, 87.5%) and described in the methods (Q10, 87.5%). Discussions and conclusions were justified by the results (Q11, 100%) with no conflicts of interests (Q13, 100%), yet, 37.5% of the authors omitted or did not fully investigate the study’s limitations (Q12). Detailed scores for each level of bias and each individual study are presented in S1 and S2 Tables.

Characteristics of included studies

Among the 24 identified papers, 15 included sessions that were recorded both at home and in the lab during one [33, 35, 3845, 51], two [31, 32], or three visits [36, 37]; these studies included an initial calibration/validation in a supervised environment for the development of ad-hoc algorithms and then subsequent implementation/testing in an unsupervised setting. Besides the number of testing days and lab sessions, the exact duration of each lab assessment was not always specified, thus hindering the reproducibility of the protocol. In contrast, nine articles described data collection that was exclusively undertaken at home [34, 4650, 5254] (Table 2).

Sample sizes ranged from seven [31, 41] to 125 [51] PwP, and from nine [31] to 67 [39] controls in laboratory environments. The same numbers for at-home tests ranged from one [33, 52] to 170 [50] PwP, and from one [33] to 172 [50] controls. In 13 cases, PwP were asked to fill a diary in order to track activities[31, 36, 37, 53], medication intake [31, 32, 34, 35] and symptoms [34, 41, 4547, 52, 54] (Table 2).

Data were collected by accelerometers alone (in 46.7% of the studies recording in labs and 50% of the studies at-home) [33, 3537, 41, 4447, 4951, 53], in combination with gyroscopes (lab: 33.3%, home: 33.3%) [3133, 39, 42, 43, 48, 52] or along with gyroscopes and magnetometers (lab: 20%, home: 16.7%) [34, 38, 40, 51, 54]. Authors used off-the-shelf devices such as the AX3 (Axivity, York, UK) [44, 45, 50, 51], DynaPort (McRoberts, The Hague, Netherlands) [33, 39, 42, 43, 48], GT3X (ActiGraph, Pensacola, USA) [53], Mimamori-gait system (Mitsubishi Chemical, Tokyo, Japan) [36, 37], Mobi8 (TMSI International, Oldenzaal, The Netherlands) [33], MOX5 (Maastricht Instruments, Maastricht, The Netherlands) [52], Opal (APDM, Portland, USA) [34, 38, 40, 51, 54] and Parkinson’s Kinetigraph (Global Kinetics Corporation, Melbourne, Australia) [35, 36]. In five studies, volunteers wore prototype sensors [31, 32, 41, 47, 49] (Fig 2). Data collection frequently lasted for a week and ranged from one [31, 36, 37, 41, 46, 47, 49] to 14 days [52] (Fig 3 and Table 2).

Fourteen works investigated gait impairments, eight of which focused on walking [31, 33, 36, 37, 4244, 51], three on turning [38, 40, 48], two on falls [39, 50] and one on physical activity [53]. Ten articles examined symptoms, side-effects of treatments, and their fluctuations, including two on bradykinesia [32, 35], four on tremor [34, 47, 52, 54], four on dyskinesia [34, 35, 45, 46] and four on the on/off state [41, 45, 46, 49] (Table 2). During gait impairment monitoring, sensors were typically placed at the lower back, in 63.6% and 57.1% of the works taking place in the lab or at-home, respectively [33, 38, 39, 4244, 48, 50, 51]. Lower back sensors were also combined with IMUs at the top of each foot (lab: 9.1%, home: 14.3%) [38, 40], waist (lab: 18.2%, home: 21.4%) [36, 37, 53], and left shank (lab: 9.1%, home: 7.1%) [31]. To monitor symptoms and their fluctuations, typical sensor positions included the waist (lab: 25%, home: 20%) [41, 49], wrist (lab: 25%, home: 20%) [35, 46, 47], both wrists (lab: 25%, home: 30%) [45, 52, 54] or in a combination of both ankles and the waist (lab: 25%, home: 20%) [32, 34] (Table 2).

Aims, outcome measures, and types of analysis

Fourteen articles investigated gait impairments with the aim of assessing different mobility tendencies and habits in daily life (Tables 2 and 3). Kinematics [31, 33, 3638, 40, 43, 44], also in combination with frequency measures [33, 39, 42, 51] were computed to study PD and healthy subjects [31, 33, 3638, 40, 43, 44, 53], or different PD populations such as recently and previously diagnosed patients [31], fallers and non-fallers [39, 50], and subjects with or without freezing-of-gait [42, 48, 50]. In order to extract kinematic and frequency parameters, walk detection algorithms were implemented in seven cases [31, 36, 37, 39, 42, 44, 50, 51], while turning algorithms in three [38, 40, 48].

Table 3. Aim, outcome measures, type of analyses, and results of the studies.

Ten articles studied symptoms and their fluctuations with the intention of detecting bradykinesia [32, 35, 41, 49], tremor [34, 47, 52, 54], dyskinesia [34, 35, 41, 45, 46, 49], and on/off state episodes [41, 45, 46, 49]. Supervised machine learning approaches, such as Artificial Neural Networks (ANN) [45], Fuzzy logic algorithms [35], linear regression [52] and Support Vector Machine (SVM) [32] models were used in this context. One publication used multiple instance learning algorithms [34], namely, the Diverse Density (DD), Expectation Maximization version of Diverse Density (EM-DD), Discriminative variant of the axis-parallel hyper-rectangle (ID-APR), Multiple instance learning k-Nearest Neighbor (MIL-kNN) and Multiple Instance Support Vector Machine (MI-SVM). Finally, four studies used thresholds and analyses of frequency patterns [41, 47, 49, 54]. Walk [41, 49, 54] and activity recognition [32] algorithms were also employed in order to assess symptoms during specific patients’ actions (Tables 2 and 3).

Results of the included studies

Yoneyama et al. (2013/2014) [36, 37] found that the average duration of the gait cycle was longer in PwP (1.16 ± 0.20 s) compared to controls (1.08 ± 0.19 s; p < 0.001). Similarly, Del Din et al. (2016) [44] reported that Parkinsonians walked with slower and shorter steps (step velocity:1.038 ± 0.422 m/s and 1.103 ± 0.411 m/s for PD and controls, respectively; p < 0.001). Moreover, PwP presented less consistent (e.g. step time variability: 0.175 ± 0.156 s for control and 0.181 ± 0.179 for PD; p = 0.07) and asymmetric (e.g. step time asymmetry: 0.093 ± 0.086 for control and 0.098 ± 0.142 for PD; p = 0.116) walking patterns [44], with fluctuations in kinematics and frequency measures compared to healthy subjects [31, 33, 44].

Three studies also investigated turning [38, 40, 48] and confirmed that PwP take shorter turns (2.0 s and 2.2 s for PD and control, respectively; p = 0.001) with smaller angles (92.0° and 95.2° for PD and control, respectively; p = 0.001) [38]. In addition, PwP completed the turning movement at a slower pace than controls (turn mean velocity: 38 ± 5.7°/s and 43.3 ± 4.8°/s, respectively; p = 0.04) and with a greater number of steps (mean number of steps: 3.2 ± 0.8 and 1.7 ± 1.1, respectively; p = 0.04) [40].

One publication investigated the correlation of the monitored overall steps taken (3615/day) and time spent in moderate-to-vigorous-physical-activities (MVPA, 8.1 min/day) with the self-reported activity using the Physical Activity Scale in the Elderly–PASE; there was a moderate correlation for steps (r = 0.56, p = 0.003), but practically no correlation for MVPA (r = -0.003, p = 0.98) [53]. Finally, two works estimated that falls occurred most frequently in PwP with a more variable, less consistent walking pattern [39, 50]; furthermore frequency sensor-derived measures were successfully able to predict future falls even in patients with no previous fall history [39].

When assessing symptoms at-home, Pastorino et al. [32] classified bradykinesia with respect to the UPDRS outcome as measured by clinicians twice per day and achieved an accuracy of 68.3 ± 8.9% with the standard SVM and 74.4 ± 14.9% with a meta-analysis algorithm. Das et al. [34] obtained an accuracy versus symptom diaries of over 90% for both dyskinesia and tremor detection with a multiple instance learning ID-APR classifier. During a recording of ten days, a significant correlation (p < 0.0005) with an r = 0.64 between global median bradykinesia and UPDRS, and a correlation (p < 0.05) with a margin of error of 3.9 (over a range 0–8) between global median dyskinesia and UPDRS was found by Griffiths et al. [35]. Pérez-López et al. [41] developed an algorithm for the on/off state events recognition based on threshold detection and analysis of frequency patterns with a sensitivity of 99.9% and a specificity of 99.9% (compared to the symptom diary). Rodriguez-Molinero et al. [49] has built upon the previous study, increasing the sample size to 23 PwP and achieving an accuracy of 92.20%. Fisher et al. [45] built an ANN classifier that was validated from symptom diaries with a sensitivity ranging from 38% to 52% and specificity from 83% to 93% for the on/off states and for dyskinesia. The method implemented by Ossig et al. [46] had a moderate-to-strong correlation with subject diaries for on/off states and dyskinesia (p-values ranging from 0.404 to 0.658). For the tremor assessment, Battista and Romaniello et al. [47] accomplished a sensitivity of 99.3%, a specificity of 99.6%, and an accuracy of 98.9% as against the tremor diaries; Heijmans et al. [52] reported correlations of up to r = 0.43, when compared to diaries, while McNames et al. [54] detected tremor presence (incorrectly) just 1.1% of the time or less in healthy volunteers.


The main aim of the present work is to review and compare previous studies on the monitoring of PwP using only wearable inertial sensors and with at least one data capture carried out during unsupervised home activities. The intent was to inform future works in which the authors aim to use body-fixed-sensors for extended periods of time in scenarios where data captures are not monitored either directly or via a videotape.

As a matter of fact, the evaluation of PD requires extensive judgement from highly-trained professionals, yet clinical assessments in a clinical setting provide only a partial overview of the disease’s pathological progression [55]. In addition, numerous episodes related with PD are challenging to detect during laboratory-based short-term observations. To consistently analyse motor symptoms, fluctuations and gait impairments, long observation windows are required due to the complexity and sporadicity of such events [21].

Wearable motion sensors are able to monitor PwP outside of standard clinical environments (for example, in private homes or community dwellings), and provide technically and clinically relevant information for clinicians and patients; therefore, a continuous assessment of the pathology may improve the quality of life of PwP, allowing them to preserve their independence and avoid additional disease complications. [12, 56, 57].

Characteristics of the studies

For the purpose of gathering large datasets from IMUs recordings lasting from one to 14 days, the most frequently used off-the-shelf devices were the DynaPort, Opal and AX3 (Fig 2), while five works used inertial non-commercial prototypes. The majority of the studies adopted off-the-shelf devices and off-line algorithm solutions. However, a potential implementation of ad-hoc hardware and on-board algorithms could enhance real-time feedbacks and ultimately have a meaningful impact in the life of patients living, for instance, in rural communities and remote areas [35, 46]. In both cases, the direct manipulation of raw data, gathered during the free-living acquisitions, avoids the use of aggregated data (i.e. step, distance) generated by “black box” software of commercial devices.

In the reviewed articles, diaries were completed by PwP or caregivers in order to track daily activities, medication intake, and symptom occurrences. However, the use of self-report for a complex task, such as the self-detection and recording of motor status over a prolonged period, may lead to misinterpretations and errors, particularly in PwP who have impaired cognition [58]. Patients may not always be able to correctly identify their own motor fluctuations and symptoms or they may log motor symptoms in incorrect time slots, or forget to update the records and then complete them many hours later from a recalled general state of function. Reportedly, diaries are not a reliable means of comparison; for example, Erb et al. [58] found that 38% of PwP in this study omitted approximately 25% of entries. However, developing digital versions, with alerts and prompts, may lessen the drawbacks typically associated with traditional paper-based diaries for PwP [59], while the involvement of caregivers trained in the data collection could benefit the quality of the reports.

The number of subjects involved in the data collections is another important aspect with an impact on the results. Sample sizes varied considerably among studies and ranged from one [33, 52] to 170 PwP, [50] from one [33] to 172 [50] controls, and from 1 [52] to 342 [50] volunteers in total (PwP and controls) in unsupervised environments. No pre-study calculation was reported in any of the papers to justify the sample size chosen. As a consequence, the small number of volunteers in certain experimental protocols generated less conclusive and decisive results in terms of statistical power.

Devices’ number and placement were various, depending on the outcomes measured. Concerning impaired locomotion, the center of mass was extensively used in literature to measure movement performance and level of stability [6062]. Accordingly, to monitor activities such as walking and turning, most of the papers agreed to adopt a single sensor worn close to the waist [36, 37, 53] and lower back [33, 38, 39, 4244, 48, 50, 51]. Besides, PwP may exhibit asymmetric walk due to the different level of impairment of the lower limbs, characterized by a reduction in walking speed, shuffling steps, and limited foot lifting [3]. Consequently, a sensor attached on the single limb would capture recordings with large variations in gait patterns and it would give just a partial overview of the patient’s status.

Sensor positioning and number is also crucial for the assessment of multiple symptoms on different subjects. In fact, tremor, dyskinesia, bradykinesia, and other PD related motor fluctuations affect upper and lower limbs differently depending on the manifestation and stage of the disease [3]. Thus, a combination of several devices might be more suitable for multiple and concurrent evaluations, however this would compromise the comfort of the system. Yet, given that fewer wearable devices enhance the acceptability, wearability and usability of the system, a sensor on the wrist may offer a good trade-off between applicability and end-user convenience.

Finally, given the potential continuous long-term adoption of wearable systems by PwP, aspects which were neglected in the identified papers, such as a system’s comfort of use, set-up process, instructions for use, support, aesthetics and display, should always be considered to guarantee long-term acceptability and efficacy of the system. For instance, the FDA-approved Parkinson’s Kinetigraph system (PKG), which provides continuous, objective, ambulatory assessments of PD symptoms, has been proved to show high patient acceptability, with 81% of the users reporting satisfactory outcomes [63]. These considerations are crucial if the final purpose is to gather large datasets and if PwP have to interact on a daily basis with the system.

Aim, outcome measures, type of analyses, and results

Kinematic parameters, such as duration of gait cycle, step length, and velocity, were clearly differentiated between the PD and healthy populations. In fact, PwP walked slower and with shorter steps [36, 37, 44]. Less consistent gait patterns with major fluctuations in kinematics and frequency measures were also observed [31, 33, 44]. Findings also underlined differences in turning [38, 40, 48], showing patients taking shorter turns with smaller angles and completing the turning movement slower and with a greater number of steps. Concerning the risk of falling, the relationship between the level of activity and impairments is still a matter of debate among the scientific community. On one side, more active patients could be more susceptible to falls since they are exposed to more unsafe situations, but on the other hand they could be at a lower risk of falling due to a better general health condition. Two reviewed articles estimated that falls occurred significantly more frequently in PwP with a less consistent walking pattern [39, 50], while fallers seemed to have a reduced capability to regulate gait due to a partial loss of postural stability [64]. Inertial wearable device can detect such impaired walking patterns and predict future falls even in patients with no previous fall history [39].

To evaluate tremor at-home, two papers reported an accuracy against the symptom diary higher than the 90% [34, 47]. In particular, Battista and Romaniello et al. [47] presented a promising method based on the spectral analysis of inertial data from a single wrist worn sensor, in conjunction with the detection of specific movement patterns generally related with Parkinsonism. To assess bradykinesia and dyskinesia, Griffiths et al. [35] implemented a fuzzy logic approach using data collected from an accelerometer on the most affected wrist; these algorithms are the core of the PKG, the first FDA-approved device for the continuous assessment of PD symptoms. In addition, regarding dyskinesia, Fisher et al. [45] developed an ANN classifier that was validated from symptom diaries obtaining a promising level of specificity (93%) but still with a low sensitivity level (38%). Finally, to detect on/off episodes, Pérez-López et al. [41] and Rodriguez-Molinero et al. [49] developed an algorithm based on the extraction of gait features from an accelerometer on the waist. The algorithm showed an accuracy of 92.2% when compared to the results of the diaries, however this approach relied upon gait parameters and required patient’s movement; therefore, it might not be suitable for the recognition during the advanced stage of the disease when PwP are mostly inactive.


The systematic review included 24 studies on the monitoring of PD using inertial sensors during unsupervised home activities. Previous articles already underlined how the well-know “Hawthorne observation effect” [20] could influence the reliability of data gathered in a laboratory setting since participants perform better when completing scripted tasks and while observed by a clinician. Furthermore, episodes associated with PD usually require long periods of observation because of their complexity (i.e. the on/off phenomenon) or rarity (i.e. freezing of gait phenomenon). As a consequence, home based data captures could generate more complete and exhaustive results in the analysis of the Parkinson’s disease.

Fourteen articles focused on postural and gait disturbances [31, 33, 3640, 4244, 48, 50, 51, 53] with the intention of evaluating mobility in daily life. The majority of the studies agreed that a position close to the center of mass (waist or lower back) was ideal for impaired gait analysis. Kinematic parameters, such as duration of gait cycle, step length, and velocity, were shown to be capable of discriminating PD and healthy subjects. Furthermore, researchers reported less consistent gait patterns in patients that may be used to predict falls in the Parkinsonian population [39].

Ten articles investigated symptoms and their fluctuations aiming to detect bradykinesia, tremor, dyskinesia, and on/off state episodes [32, 34, 35, 41, 4547, 49, 52, 54]. Even if researchers were able to achieve accuracies over 90% in a free-living environment [34, 41, 47, 49], the assessment of multiple symptoms on different subjects necessitated the employment of a high number of wearable devices, compromising the user-friendliness of the system and patients’ comfort. The wrist position may offer the best compromise between performance, applicability, and end-user convenience.

In conclusion, future studies commencing an assessment of PwP for prolonged time periods may look into the a) development and testing of dedicated hardware and software for real-time feedback that would also permit the interaction between clinicians and patients, and b) the incorporation of digital versions of diaries with alerts and prompts in the study’s design that would allow the correlation between quantitative measurements and self-reported outcomes. Additionally, characteristics which were ignored by researchers, such as the system’s comfort of use, set-up process, instructions for use, support, aesthetics and display, need to be strongly considered. These reflections are fundamental for the efficacy of a health care system that will be used mostly by older people in a social environment and it should not affect patients physically or psychologically [12, 56, 57, 6570].


  1. 1. Vos T, Allen C, Arora M, Barber RM, Brown A, Carter A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016. pmid:27733282
  2. 2. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. Lancet Neurology. 2006. pmid:16361025
  3. 3. Jankovic J. Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry. 2008. pmid:18344392
  4. 4. Lang AE, Lozano AM. Parkinson’s disease. First of two parts. N Engl J Med. 1998. pmid:9761807
  5. 5. Freitas ME, Hess CW, Fox SH. Motor Complications of Dopaminergic Medications in Parkinson’s Disease. Semin Neurol. 2017. pmid:28511255
  6. 6. Anderson E, Nutt J. The long-duration response to levodopa: Phenomenology, potential mechanisms and clinical implications. Parkinsonism and Related Disorders. 2011. pmid:21530356
  7. 7. Thanvi B, Lo N, Robinson T. Levodopa-induced dyskinesia in Parkinson’s disease: Clinical features, pathogenesis, prevention and treatment. Postgraduate Medical Journal. 2007. pmid:17551069
  8. 8. Hoff JI, Van Hilten BJ, Roos RAC. A review of the assessment of dyskinesias. Movement Disorders. 1999. pmid:10495034
  9. 9. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008. pmid:19025984
  10. 10. Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of clinical diagnosis of Parkinson disease. Neurology. 2016. pmid:26764028
  11. 11. Tedesco S, Urru A, Clifford A, O’Flynn B. Experimental Validation of the Tyndall Portable Lower-limb Analysis System with Wearable Inertial Sensors. Procedia Engineering. 2016.
  12. 12. Tedesco S, Barton J, O’Flynn B. A review of activity trackers for senior citizens: Research perspectives, commercial landscape and the role of the insurance industry. Sensors (Switzerland). 2017. pmid:28587188
  13. 13. Ancillao A, Tedesco S, Barton J, O’flynn B. Indirect measurement of ground reaction forces and moments by means of wearable inertial sensors: A systematic review. Sensors (Switzerland). 2018. pmid:30081607
  14. 14. Amft O, Junker H, Tröster G. Detection of eating and drinking arm gestures using inertial body-worn sensors. Proceedings—International Symposium on Wearable Computers, ISWC. 2005.
  15. 15. Mancini M, Schlueter H, El-Gohary M, Mattek N, Duncan C, Kaye J, et al. Continuous Monitoring of Turning Mobility and Its Association to Falls and Cognitive Function: A Pilot Study. Journals Gerontol—Ser A Biol Sci Med Sci. 2016. pmid:26916339
  16. 16. Scanaill CN, Carew S, Barralon P, Noury N, Lyons D, Lyons GM. A review of approaches to mobility telemonitoring of the elderly in their living environment. Ann Biomed Eng. 2006. pmid:16550450
  17. 17. Yang CC, Hsu YL. A review of accelerometry-based wearable motion detectors for physical activity monitoring. Sensors. 2010. pmid:22163626
  18. 18. Troiano RP, McClain JJ, Brychta RJ, Chen KY. Evolution of accelerometer methods for physical activity research. Br J Sports Med. 2014. pmid:24782483
  19. 19. Bloem BR, Grimbergen YAM, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson’s disease. J Neurol. 2001. pmid:11757958
  20. 20. McCarney R, Warner J, Iliffe S, Van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: A randomised, controlled trial. BMC Med Res Methodol. 2007. pmid:17608932
  21. 21. Warmerdam E, Hausdorff JM, Atrsaei A, Zhou Y, Mirelman A, Aminian K, et al. Long-term unsupervised mobility assessment in movement disorders. The Lancet Neurology. 2020. pmid:32059811
  22. 22. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson’s disease. Movement Disorders. 2013. pmid:24030855
  23. 23. Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, et al. A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease. Journal of NeuroEngineering and Rehabilitation. 2016. pmid:26969628
  24. 24. Rovini E, Maremmani C, Cavallo F. Automated Systems Based on Wearable Sensors for the Management of Parkinson’s Disease at Home: A Systematic Review. Telemedicine and e-Health. 2019. pmid:29969384
  25. 25. Thorp JE, Adamczyk PG, Ploeg HL, Pickett KA. Monitoring Motor Symptoms During Activities of Daily Living in Individuals With Parkinson’s Disease. Frontiers in Neurology. 2018. pmid:30619024
  26. 26. Del Din S, Godfrey A, Mazzà C, Lord S, Rochester L. Free-living monitoring of Parkinson’s disease: Lessons from the field. Mov Disord. 2016. pmid:27452964
  27. 27. Rovini E, Maremmani C, Cavallo F. How wearable sensors can support parkinson’s disease diagnosis and treatment: A systematic review. Frontiers in Neuroscience. 2017. pmid:29056899
  28. 28. Morgan C, Rolinski M, McNaney R, Jones B, Rochester L, Maetzler W, et al. Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson’s Disease in the Home or a Home-like Environment. Journal of Parkinson’s Disease. 2020. pmid:32250314
  29. 29. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine. 2009. pmid:19621070
  30. 30. Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016. pmid:27932337
  31. 31. Moore ST, Dilda V, Hakim B, MacDougall HG. Validation of 24-hour ambulatory gait assessment in Parkinson’s disease with simultaneous video observation. Biomed Eng Online. 2011. pmid:21936884
  32. 32. Pastorino M, Cancela J, Arredondo MT, Pansera M, Pastor-Sanz L, Villagra F, et al. Assessment of bradykinesia in Parkinson’s disease patients through a multi-parametric system. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2011.
  33. 33. Weiss A, Sharifi S, Plotnik M, Van Vugt JPP, Giladi N, Hausdorff JM. Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer. Neurorehabil Neural Repair. 2011. pmid:21989633
  34. 34. Das S, Amoedo B, Torre FD La, Hodgins J. Detecting Parkinsons’ symptoms in uncontrolled home environments: A multiple instance learning approach. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2012. pmid:23366728
  35. 35. Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J, et al. Automated assessment of bradykinesia and dyskinesia in Parkinson’s disease. J Parkinsons Dis. 2012. pmid:23939408
  36. 36. Yoneyama M, Kurihara Y, Watanabe K, Mitoma H. Accelerometry-based gait analysis and its application to Parkinson’s disease assessment-Part 1: Detection of stride event. IEEE Trans Neural Syst Rehabil Eng. 2014. pmid:23661322
  37. 37. Yoneyama M, Kurihara Y, Watanabe K, Mitoma H. Accelerometry-based gait analysis and its application to parkinson’s disease assessment-Part 2: A new measure for quantifying walking behavior. IEEE Trans Neural Syst Rehabil Eng. 2013. pmid:23797284
  38. 38. El-Gohary M, Pearson S, McNames J, Mancini M, Horak F, Mellone S, et al. Continuous monitoring of turning in patients with movement disability. Sensors (Switzerland). 2014. pmid:24379043
  39. 39. Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson’s disease using a body-fixed sensor worn for 3 days. PLoS One. 2014. pmid:24801889
  40. 40. Mancini M, El-Gohary M, Pearson S, Mcnames J, Schlueter H, Nutt JG, et al. Continuous monitoring of turning in Parkinson’s disease: Rehabilitation potential. NeuroRehabilitation. 2015. pmid:26409689
  41. 41. Pérez-López C, Samà A, Rodríguez-Martín D, Català A, Cabestany J, De Mingo E, et al. Monitoring motor fluctuations in parkinson’s disease using a waist-worn inertial sensor. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2015.
  42. 42. Weiss A, Herman T, Giladi N, Hausdorff JM. New evidence for gait abnormalities among Parkinson’s disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days. J Neural Transm. 2015. pmid:25069586
  43. 43. Bernad-Elazari H, Herman T, Mirelman A, Gazit E, Giladi N, Hausdorff JM. Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor. J Neurol. 2016. pmid:27216626
  44. 44. Del Din S, Godfrey A, Galna B, Lord S, Rochester L. Free-living gait characteristics in ageing and Parkinson’s disease: Impact of environment and ambulatory bout length. J Neuroeng Rehabil. 2016. pmid:27175731
  45. 45. Fisher JM, Hammerla NY, Ploetz T, Andras P, Rochester L, Walker RW. Unsupervised home monitoring of Parkinson’s disease motor symptoms using body-worn accelerometers. Park Relat Disord. 2016. pmid:27637282
  46. 46. Ossig C, Gandor F, Fauser M, Bosredon C, Churilov L, Reichmann H, et al. Correlation of quantitative motor state assessment using a kinetograph and patient diaries in advanced PD: Data from an observational study. PLoS One. 2016. pmid:27556806
  47. 47. Battista L, Romaniello A. A novel device for continuous monitoring of tremor and other motor symptoms. Neurol Sci. 2018. pmid:29736737
  48. 48. Mancini M, Weiss A, Herman T, Hausdorff JM. Turn around freezing: Community-living turning behavior in people with Parkinson’s disease. Front Neurol. 2018. pmid:29434567
  49. 49. Rodríguez-Molinero A, Pérez-López C, Samá A, De Mingo E, Rodríguez-Martín D, Hernández-Vara J, et al. A kinematic sensor and algorithm to detect motor fluctuations in Parkinson disease: Validation study under real conditions of use. J Med Internet Res. 2018. pmid:29695377
  50. 50. Del Din S, Galna B, Godfrey A, Bekkers EMJ, Pelosin E, Nieuwhof F, et al. Analysis of Free-Living Gait in Older Adults with and Without Parkinson’s Disease and with and Without a History of Falls: Identifying Generic and Disease-Specific Characteristics. Journals Gerontol—Ser A Biol Sci Med Sci. 2019. pmid:29300849
  51. 51. Galperin I, Hillel I, Del Din S, Bekkers EMJ, Nieuwboer A, Abbruzzese G, et al. Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson’s disease. Park Relat Disord. 2019. pmid:30718220
  52. 52. Heijmans M, Habets J, Kuijf M, Kubben P, Herff C. Evaluation of Parkinson’s Disease at Home: Predicting Tremor from Wearable Sensors. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2019.
  53. 53. Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical activity in Parkinson disease. Park Relat Disord. 2019. pmid:31621608
  54. 54. McNames J, Shah V V., Mancini M, Curtze C, El-Gohary M, Aboy M, et al. A Two-Stage Tremor Detection Algorithm for Wearable Inertial Sensors during Normal Daily Activities. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2019.
  55. 55. Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s disease: Clinical manifestations. Mov Disord. 2005. pmid:15822109
  56. 56. Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O’Flynn B. Validity evaluation of the fitbit charge2 and the garmin vivosmart HR+ in free-living environments in an older adult cohort. J Med Internet Res. 2019. pmid:31219048
  57. 57. Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O’Flynn B. Accuracy of consumer-level and research-grade activity trackers in ambulatory settings in older adults. PLoS One. 2019. pmid:31112585
  58. 58. Erb MK, Karlin DR, Ho BK, Thomas KC, Parisi F, Vergara-Diaz GP, et al. mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease. npj Digit Med. 2020. pmid:31970291
  59. 59. Heijmans M, Habets JG V., Herff C, Aarts J, Stevens A, Kuijf ML, et al. Monitoring Parkinson’s disease symptoms during daily life: a feasibility study. npj Park Dis. 2019. pmid:31583270
  60. 60. Fazio P, Granieri G, Casetta I, Cesnik E, Mazzacane S, Caliandro P, et al. Gait measures with a triaxial accelerometer among patients with neurological impairment. Neurol Sci. 2013. pmid:22447360
  61. 61. Howell D, Osternig L, Chou LS. Monitoring recovery of gait balance control following concussion using an accelerometer. J Biomech. 2015. pmid:26152463
  62. 62. Betker AL, Szturm T, Moussavi Z. Center of mass approximation during walking as a function of trunk and swing leg acceleration. Annual International Conference of the IEEE Engineering in Medicine and Biology—Proceedings. 2006.
  63. 63. Dominey T, Hutchinson L, Pearson E, Murphy F, Bell L, Carroll C. Evaluating the clinical utility of the Parkinson’s KinetiGraph (PKGTM) in the remote management of Parkinson’s disease. Mov Disord. 2018.
  64. 64. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson’s disease: Relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci. 2003.
  65. 65. Giansanti D, Maccioni G, Morelli S. An experience of health technology assessment in new models of care for subjects with Parkinson’s disease by means of a new wearable device. Telemed e-Health. 2008. pmid:18578682
  66. 66. Cancela J, Pastorino M, Arredondo MT, Nikita KS, Villagra F, Pastor MA. Feasibility study of a wearable system based on a wireless body area network for gait assessment in Parkinson’s disease patients. Sensors (Switzerland). 2014. pmid:24608005
  67. 67. Cancela J, Pastorino M, Tzallas AT, Tsipouras MG, Rigas G, Arredondo MT, et al. Wearability assessment of a wearable system for Parkinson’s disease remote monitoring based on a body area network of sensors. Sensors (Switzerland). 2014. pmid:25230307
  68. 68. Piro NE, Baumann L, Tengler M, Piro L, Blechschmidt-Trapp R. Telemonitoring of patients with Parkinson’s disease using inertia sensors. Appl Clin Inform. 2014. pmid:25024764
  69. 69. Ferrari A, Ginis P, Nieuwboe A, Greenlaw R, Muddiman A, Chiari L. Handling gait impairments of persons with Parkinson’s disease by means of real-time biofeedback in a daily life environment. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2016.
  70. 70. Fisher JM, Hammerla NY, Rochester L, Andras P, Walker RW. Body-Worn Sensors in Parkinson’s Disease: Evaluating Their Acceptability to Patients. Telemed e-Health. 2016. pmid:26186307